Published online before print March 24, 2005, doi: 10.1161/01.RES.0000163980.55495.44
© 2005 American Heart Association, Inc.
Integrative Physiology |
Targeted Disruption of TGF-ß–Smad3 Signaling Leads to Enhanced Neointimal Hyperplasia With Diminished Matrix Deposition in Response to Vascular Injury
From the Department of Clinical Cell Biology (K.K., K.Y., M.F., H.K., Y.M., S.A., S.M., Y.S.), Chiba University Graduate School of Medicine; Division of Endocrinology and Metabolism (K.Y., Y.S.), Department of Internal Medicine, Chiba University Hospital; Department of Developmental Genetics (K.Y., A.S., T.T.), Chiba University Graduate School of Medicine, Chiba, Japan; and Shiraoka Research Station of Biological Science (M.K.), Nissan Chemical Industries, Ltd, Saitama, Japan.
Correspondence to Koutaro Yokote, MD, PhD, DMSci, Division of Endocrinology and Metabolism, Department of Internal Medicine, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail kyokote-cib{at}umin.ac.jp
The role of transforming growth factor (TGF)-ß and its signal in atherogenesis is not fully understood. Here, we examined mice lacking Smad3, a major downstream mediator of TGF-ß, to clarify the precise role of Smad3-dependent signaling in vascular response to injury. Femoral arteries were injured in wild-type and Smad3-null (null) male mice on C57Bl/6 background. Histopathological evaluation of the arteries 1 to 3 weeks after the injury revealed significant enhancement of neointimal hyperplasia in null compared with wild-type mice. Transplantation of null bone marrow to wild-type mice did not enhance neointimal thickening, suggesting that vascular cells in situ play a major role in the response. Null intima contained more proliferating smooth muscle cells (SMC) with less amount of collagen compared with wild-type intima. TGF-ß caused significant inhibition of cellular proliferation in wild-type aortic SMC, whereas the growth of null SMC was only weakly inhibited by TGF-ß in vitro, indicating a crucial role of Smad3 in the growth inhibitory function. On the other hand, Smad3-deficiency did not attenuate chemotaxis of SMC toward TGF-ß. TGF-ß increased transcript level of 
2 type I collagen and tissue inhibitor of metalloproteinases-1, and suppressed expression and activity of matrix metalloproteinases in wild-type SMC. However, these effects of TGF-ß were diminished in null SMC. Our findings altogether show that the loss of Smad3 pathway causes enhanced neointimal hyperplasia on injury through modulation of growth and matrix regulation in vascular SMC. These results indicate a vasculoprotective role of endogenous Smad3 in response to injury.
Key Words: transforming growth factor-ß • Smad3 • atherosclerosis • neointimal hyperplasia • smooth muscle cells
This article has been cited by other articles:
 |
|
 |
|
  V. Divakaran, J. Adrogue, M. Ishiyama, M. L. Entman, S. Haudek, N. Sivasubramanian, and D. L. Mann Adaptive and Maladptive Effects of SMAD3 Signaling in the Adult Heart After Hemodynamic Pressure Overloading Circ Heart Fail, November 1, 2009; 2(6): 633 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kundi, S. T. Hollenbeck, D. Yamanouchi, B. C. Herman, R. Edlin, E. J. Ryer, C. Wang, S. Tsai, B. Liu, and K. C. Kent Arterial gene transfer of the TGF-{beta} signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF Cardiovasc Res, November 1, 2009; 84(2): 326 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tsai, S. T. Hollenbeck, E. J. Ryer, R. Edlin, D. Yamanouchi, R. Kundi, C. Wang, B. Liu, and K. C. Kent TGF-{beta} through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H540 - H549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Matsuzaki, C. Kitano, M. Murata, G. Sekimoto, K. Yoshida, Y. Uemura, T. Seki, S. Taketani, J.-i. Fujisawa, and K. Okazaki Smad2 and Smad3 Phosphorylated at Both Linker and COOH-Terminal Regions Transmit Malignant TGF-{beta} Signal in Later Stages of Human Colorectal Cancer Cancer Res., July 1, 2009; 69(13): 5321 - 5330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yu, G. C. Sharp, and H. Braley-Mullen TGF-{beta} Promotes Thyroid Epithelial Cell Hyperplasia and Fibrosis in IFN-{gamma}-Deficient NOD.H-2h4 Mice J. Immunol., August 1, 2008; 181(3): 2238 - 2245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-W. Lin, I.-C. Chang, A. Tseng, M.-L. Wu, C.-H. Chen, C. A. Patenaude, M. D. Layne, and S.-F. Yet Transforming Growth Factor {beta} Up-regulates Cysteine-rich Protein 2 in Vascular Smooth Muscle Cells via Activating Transcription Factor 2 J. Biol. Chem., May 30, 2008; 283(22): 15003 - 15014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fu, M. J. Corbley, L. Sun, J. E. Friedman, F. Shan, J. L. Papadatos, D. Costa, F. Lutterodt, H. Sweigard, S. Bowes, et al. SM16, an Orally Active TGF-{beta} Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 665 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido TGF-{beta} signaling in vascular fibrosis Cardiovasc Res, May 1, 2007; 74(2): 196 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Arany, K. C. Flanders, T. Kobayashi, C. K. Kuo, C. Stuelten, K. V. Desai, R. Tuan, S. I. Rennard, and A. B. Roberts Smad3 deficiency alters key structural elements of the extracellular matrix and mechanotransduction of wound closure PNAS, June 13, 2006; 103(24): 9250 - 9255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wang, X. R. Huang, E. Canlas, K. Oka, L. D. Truong, C. Deng, N. A. Bhowmick, W. Ju, E. P. Bottinger, and H. Y. Lan Essential Role of Smad3 in Angiotensin II-Induced Vascular Fibrosis Circ. Res., April 28, 2006; 98(8): 1032 - 1039. [Abstract] [Full Text] [PDF]
|
|